Let us empower you to be a pharmacovigilance superhero · Let us empower you to be a...

6
adis.com Learn More Let us empower you to be a pharmacovigilance superhero... Concise, up-to-date and reliable adverse event information that can be used for many different pharmacovigilance activities. Pharmacovigilance Insight Comprehensive database for pharmacovigilance literature monitoring Reactions Pharmacovigilance Service Customized ICSR literature monitoring solutions to streamline your regulatory obligations with confidence Drug Safety Expert evaluations of drug treatment safety issues Reactions Weekly The unparalleled source for pharmacovigilance information

Transcript of Let us empower you to be a pharmacovigilance superhero · Let us empower you to be a...

Page 1: Let us empower you to be a pharmacovigilance superhero · Let us empower you to be a pharmacovigilance superhero... Concise, up-to-date and reliable adverse event information that

adis.com

Learn More

Let us empower you to be a pharmacovigilance superhero...Concise, up-to-date and reliable adverse event information that can be used for many different pharmacovigilance activities.

Pharmacovigilance InsightComprehensive database for pharmacovigilance literature monitoring

Reactions Pharmacovigilance ServiceCustomized ICSR literature monitoring solutions to streamline your regulatory obligations with confidence

Drug SafetyExpert evaluations of drug treatment safety issues

Reactions Weekly The unparalleled source for pharmacovigilance information

Page 2: Let us empower you to be a pharmacovigilance superhero · Let us empower you to be a pharmacovigilance superhero... Concise, up-to-date and reliable adverse event information that

4

adis.comDrug Safety

• Invited & submitted reviews

• Original research

• MEDLINE indexed

• Impact Factor 3.634

• 12 issues per year

The Official Journal of the International Society of Pharmacovigilance

Special rates available for ISoP members

Drug SafetyExpert evaluations of drug treatment safety issuesThe premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment, risk management and medication error prevention.

Drug Safety specializes in definitive reviews on the epidemiology, clinical features, prevention and management of adverse effects of individual drugs and drug classes.

The journal also features reviews covering drug use in particular ‘at-risk’ patient groups, concept reviews on methodology, editorials and commentaries on topical issues and high quality original research focusing on the clinical implications of drug safety treatment issues.

What our readers sayHighly recognized authors and up-to-date topics; I consider this the most relevant journal at the moment when working in a leading position in pharmacovigilance

It is the best out there

Provides cutting edge, useful information that can be immediately applied to clinical practice

Quotes from Adis readership surveys

Personal and institutional subscriptions available

Page 3: Let us empower you to be a pharmacovigilance superhero · Let us empower you to be a pharmacovigilance superhero... Concise, up-to-date and reliable adverse event information that

5

adis.comReactions Weekly

• 50 issues per year

• Newsletter

Reactions WeeklyThe unparalleled source for pharmacovigilance informationReactions Weekly is the unique one-stop-shop for all your adverse drug reaction needs, bringing you up-to-the minute summaries of the world's adverse drug reaction news and published adverse drug reaction case reports. Reactions Weekly provides a weekly round-up of adverse drug reaction news including labelling changes, drug withdrawals due to safety issues, adverse reaction research and current issues in drug safety.

Content is sourced from journals, scientific meetings, media releases, regulatory agency websites, and bulletins from the National Centers that participate in the WHO International Drug Monitoring Programme.

• Clinical studies

• Case reports

• Incidence studies

• Guidelines

• Meeting reports

• Media Releases

• Regulatory News

Page 4: Let us empower you to be a pharmacovigilance superhero · Let us empower you to be a pharmacovigilance superhero... Concise, up-to-date and reliable adverse event information that

NO

N P

RIN

TIN

G A

REA

6

adis.com Pharmacovigilance Insight

What our readers sayEasy-to-use search engine providing rapid and unrivalled access to the world‘s ADR literature. A must-have source for all Medicines Information Centres

David Anderton, Derby Hospitals NHS Foundation Trust

Adverse Drug Reaction Literature Surveillance on DemandPharmacovigilance Insight is a comprehensive database for pharmacovigilance literature monitoring. Updated daily it gives you reliable, fast, and easy access to adverse drug reaction case reports, drug safety studies and regulatory news. The database provides comprehensive identification, indexing, and summaries of all adverse drug reactions published worldwide from the following sources:

• Over 7000 unique MEDLINE and EMBASE indexed journals and companion supplements

• Proceedings from approximately 100 major scientific meetings

• News from the National Centers that participate in the WHO International Drug Monitoring Programme for which the Uppsala Monitoring Centre provides technical support and coordination

• News from regulatory agency websites and media releases

Reliable surveillance of the drug safety landscape • Identify all Individual Case Safety Reports (ICSR) for any drug

• Identify key studies focusing on adverse drug reactions

• Identify previous reports of specific adverse drug reactions

• Identify drug safety signals for specific drugs or drug classes

• Identify safety issues worldwide for all drugs in your market

Powerful database with easy to use features • Detailed searching by drug, drug class, adverse event, country, subject group or

publication citation

• Fast, specific full text search with Boolean logic

• Fully referenced summaries of key points including timeframes, investigations, treatment and outcomes with the capability to link back to the original article

• Email alerts delivered to your desktop daily, weekly or monthly

• Sophisticated charting and exporting tools

• Records dating back to 1982 to provide the most comprehensive, reliable, worldwide literature monitoring of case reports available

Page 5: Let us empower you to be a pharmacovigilance superhero · Let us empower you to be a pharmacovigilance superhero... Concise, up-to-date and reliable adverse event information that

adis.com

NO

N P

RIN

TIN

G A

REA

1

RPS

Visit adis.comfor more details

Reactions Pharmacovigilance ServiceStreamline your ICSR literature monitoring with confidence Save time and resources required to meet your adverse event reporting obligations to regulatory agencies by relying on Reactions Pharmacovigilance Service to monitor the litera-ture for published Individual Case Safety Reports (ICSR).

Have confidence that nothing is missed as a result of our extensive coverage and variety of sources

• Approximately 7000 journals, including all MEDLINE and EMBASE indexed journals

• Proceedings from approximately 100 major scientific meetings

• Newsletters from the national centres participating in the WHO International Drug Monitoring Programme

• Regulatory agency & pharmaceutical company websites

• Media releases

Easily integrate into your existing Pharmacovigilance process by customizing content, delivery, and timing to meet your needs:

• Summaries of ICSR delivered as a narrative or in E2B compatible form with all relevant ICH E2B (M) fields populated including the latest version of MedDRA coding

• Monitor specific drugs or drug classes

• Delivery through data feed or email alerts

• Daily, weekly, or monthly alerts available

• ICSRs are processed on a daily basis

Additional services are also available to help you meet your safety reporting obligations

• Aggregate safety searches

• Local language journal monitoring

Page 6: Let us empower you to be a pharmacovigilance superhero · Let us empower you to be a pharmacovigilance superhero... Concise, up-to-date and reliable adverse event information that

adis.comSales Contacts

H9473 | Images: melhi/istockphoto, papa/fotolia.com

Translating research into clinical practice Adis is a well-established and respected global brand and has been publishing high quality journals, focusing on translating research into clinical practice for over 40 years. In addition to its range of Pharmacovigilance solutions, Adis journals and newsletters also cover the following areas:

• Clinical Pharmacology

• Biotechnology and Personalized Medicine • Health Economics and Outcomes Research

• Specialized Therapy Areas

For further information please visit Adis.com

Would you like to know more? Contact Springer today.Visit springer.com/salescontacts to find your local Springer representative!

Contact us !